This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ariëns, R. A. S. Articles by Grant, P. J. Search for Related Content PubMed PubMed Citation Articles by Ariëns, R. A. S. Articles by Grant, P. J. Related Collections Risk Factors Coagulation and fibronolysis

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2012-2016.)
© 1999 American Heart Association, Inc.

Thrombosis

Subunit Antigen and Activity Levels of Blood Coagulation Factor XIII in Healthy Individuals

Relation to Sex, Age, Smoking, and Hypertension

R. A. S. Ariëns; H. P. Kohler; M. W. Mansfield; P. J. Grant

From the Unit of Molecular Vascular Medicine, University of Leeds, Leeds, UK.

Correspondence to Robert A.S. Ariëns, BSc, PhD, Unit of Molecular Vascular Medicine, University of Leeds, G Floor, Martin Wing, Leeds General Infirmary, Leeds LS1 3EX, UK. E-mail r.a.s.ariens{at}leeds.ac.uk

Abstract—Factor (F) XIII covalently cross-links and stabilizes the fibrin-clot. Recent evidence suggests a role for FXIII in atherothrombotic diseases, but no information is available regarding the association of FXIII with common risk factors. The aim of this study was to investigate the relationship of FXIII with age, sex, smoking, and hypertension. Plasma levels of FXIII A-subunit antigen, FXIII B-subunit antigen, and FXIII cross-linking activity were measured in 612 healthy individuals (250 men and 362 women). FXIII A- and B-subunit levels were correlated significantly with age in both men (r=0.21, P=0.001, and r=0.17, P=0.008, respectively) and women (r=0.20, P<0.0005, and r=0.13, P=0.011, respectively). FXIII B-subunit levels and activity were correlated significantly with FXIII A-subunit levels (r=0.60, P<0.0005, and r=0.14, P<0.0005, respectively) and fibrinogen (r=0.26, P<0.0005, and r=0.14, P=0.001, respectively). Women had higher levels of FXIII A-subunit (111.8% versus 105.2%, P<0.01) and B-subunit (109.5% versus 103.8%, P<0.01) than did men. FXIII A-subunit was significantly increased in smokers (117.0% versus 104.6%, P<0.0005) and in subjects with hypertension (114.9% versus 107.8%, P<0.05). In a multiple regression model, FXIII A-subunit was significantly increased by female sex (+6.4%, P<0.007), smoking (+12.3%, P<0.0005), and increasing age (+3.7% per 10 years, P<0.0005). FXIII B-subunit was significantly related to female sex and fibrinogen, and FXIII activity was significantly related to fibrinogen levels. In conclusion, the FXIII A-subunit level increases significantly with female sex, age, and smoking, whereas FXIII B-subunit and FXIII activity are associated with FXIII A-subunit level and fibrinogen. Although evidence for a causal relationship between FXIII A-subunit and vascular disease is not available, these results might suggest a role for elevated FXIII A-subunit levels in the pathogenesis of vascular disease.

Key Words: factor XIII • sex • age • smoking • hypertension

This article has been cited by other articles:

				M. de Lange, T. Andrew, H. Snieder, D. Ge, T. S. Futers, K. Standeven, T. D. Spector, P. J. Grant, and R. A.S. Ariens Joint Linkage and Association of Six Single-Nucleotide Polymorphisms in the Factor XIII-A Subunit Gene Point to V34L As the Main Functional Locus Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1914 - 1919. [Abstract] [Full Text] [PDF]

				V. F. Tapson The Role of Smoking in Coagulation and Thromboembolism in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 71 - 77. [Abstract] [Full Text] [PDF]

				E. J. Dunn, R. A. Ariens, M. de Lange, H. Snieder, J. H. Turney, T. D. Spector, and P. J. Grant Genetics of fibrin clot structure: a twin study Blood, March 1, 2004; 103(5): 1735 - 1740. [Abstract] [Full Text] [PDF]

				J. D. Mills, R. A.S. Ariens, M. W. Mansfield, and P. J. Grant Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery Disease Circulation, October 8, 2002; 106(15): 1938 - 1942. [Abstract] [Full Text] [PDF]

				K. F. Standeven, R. A.S. Ariens, P. Whitaker, A. E. Ashcroft, J. W. Weisel, and P. J. Grant The Effect of Dimethylbiguanide on Thrombin Activity, FXIII Activation, Fibrin Polymerization, and Fibrin Clot Formation Diabetes, January 1, 2002; 51(1): 189 - 197. [Abstract] [Full Text] [PDF]

				A. P. Reiner, S. M. Schwartz, M. B. Frank, W.T. Longstreth Jr, L. A. Hindorff, G. Teramura, F. R. Rosendaal, L. K. Gaur, B. M. Psaty, D. S. Siscovick, et al. Polymorphisms of Coagulation Factor XIII Subunit A and Risk of Nonfatal Hemorrhagic Stroke in Young White Women Editorial Comment Stroke, November 1, 2001; 32(11): 2580 - 2587. [Abstract] [Full Text] [PDF]

				R. A. S. Ariens, H. Philippou, C. Nagaswami, J. W. Weisel, D. A. Lane, and P. J. Grant The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure Blood, August 1, 2000; 96(3): 988 - 995. [Abstract] [Full Text] [PDF]

				A. Elbaz, O. Poirier, S. Canaple, F. Chedru, F. Cambien, and P. Amarenco The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction Blood, January 15, 2000; 95(2): 586 - 591. [Abstract] [Full Text] [PDF]